Research Proposal References

advertisement
References
1. Baekelandt V., DeStrooper B., Nuttin B., Debyser Z. 2000. Gene therapeutic strategies
for neurodegenerative diseases. Current Opinion in Molecular Therapeutics
2:540-554.
2. Bunnell B & Morgan RA. 1998. Gene therapy for infectious deceases. Clinical
Microbiology Reviews 11:42-56.
3. Decker T., Muller Mathias., Stockinger Silvia. 2005. The yin and yang of type I
interferon activity in bacterial infection. Nature Reviews Immunology 5:675-687.
4. Isner, J.M. Myocardial gene therapy. 2002. Nature 415, 234-239.
5. Marshall E. 1999. Clinical Trials- Gene therapy death prompts review of adenovirus
vector. Science 286:2244-2245.
6. McCaffrey AP., Fawcett., Nakai H., McCaffrey L., Ehrhardt A., Pham T., Pandy K.,
Xu H., Feuss S., Storm T., Kay MA. 2008. The host response to adenovirus,
helper-dependent adenovirus, and adeno-associated virus in mouse liver.
Molecular Therapy 16(5):931-941.
7. Nusionzon I & Horvath CM. 2006. Positive and negative regulation of the innate
antiviral response and beta interferon gene expression by deacetylation. Molecular
and Cellular Biology 26(8):3106-3113.
8. Thomas CE., Ehrhardt A., Kay MA. 2003. Progress and problems with the use of viral
vectors for gene therapy. Nature Reviews Genetics 4:346-358.
9. Tseng JF & Mulligan RC. 2002. Gene therapy for pancreatic cancer. Surgical
Oncology Clinics of North America 11(3):537-569.
10. Wolkowicz R., Nolan GP. 2005. Gene therapy progress and prospects: Novel gene
therapy approaches for AIDS. Gene Therapy 12: 467-476.
11. Muruve DA. 2004. The Innate Immune Response to Adenovirus Vectors. Human
Gene Therapy 15(12): 1157-1166.
12. Nociari M., Ocheretina O., Schoggins JW., Falck-Pedersen E. 2007. Sensing infection
by adenovirus: Toll-like receptor-independent viral DNA recognition signals
activation of the interferon regulatory factor 3 master regulator. Journal of
Virology 81(8): 4145-4157.
13. Nusinzon I., Horvath. 2003. Interferon-stimulated transcription and innate antiviral
immunity require deacetylase activity and histone deacetylase 1. PNAS 100(25):
14742-14747.
14. Hartman ZC., Kiang A., Everett RS., Serra D., Yang XY., Clay TM., Amalfitano A.
2007. Adenovirus infection triggers a rapid myD88-regulated transcriptome
response cirtical to acute phase and adaptive immune responses in vivo. Journal
of Virology 81(4): 1796-1812.
15. Nusinzon I., Horvath CM. 2005. Unexpected roles for deacetylation in interferon- and
cytokine – induced transcription. Journal of Interferon and Cytokine Research
25:745-748.
16. Akira Shizuo. 2003. Toll-like Receptor Signaling. The Journal of Biological
Chemistry 278(40):38015-38108.
17. Muruve DA., Petrilli V., Zaiss AK., White LR., Clark SA., Ross PJ,. Parks RJ.,
Tschopp J. 2008. The inflammasome recognizes cytosolic microbial and host
DNA and triggers and innate immune response. Nature 452: 103-107.
18. Dorn A., Zhao H., Granberg F., Hosel M., Webb D., Sevensson C., Pettersson U.,
Doerfler W. 2005. Identification of specific cellular genes up-regulated late in
adenovirus type 12 infection. Journal of Virology 79(4):2404-2412.
Download